These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 36742277

  • 1. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.
    Dubey H, Goel H, Verma S, Gupta S, Tanwar K, Rahul E, Kapoor G, Vasantharaman J, Ranjan A, Tanwar P, Chopra A.
    Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277
    [Abstract] [Full Text] [Related]

  • 2. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
    Guan J, Ma J, Chen B.
    Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics.
    Dampmann M, Flossdorf S, Keyl J, Reinhardt HC, Hanoun C.
    Acta Haematol; 2024 May 22; ():1-8. PubMed ID: 38763126
    [Abstract] [Full Text] [Related]

  • 5. Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia.
    Tessier C, LeBlanc R, Roy J, Trudel S, Côté J, Lalancette M, Boudreault JS, Lemieux-Blanchard É, Kaedbey R, Pavic M.
    Cancer Med; 2024 Sep 22; 13(17):e70192. PubMed ID: 39225552
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic aberrations and survival in plasma cell leukemia.
    Tiedemann RE, Gonzalez-Paz N, Kyle RA, Santana-Davila R, Price-Troska T, Van Wier SA, Chng WJ, Ketterling RP, Gertz MA, Henderson K, Greipp PR, Dispenzieri A, Lacy MQ, Rajkumar SV, Bergsagel PL, Stewart AK, Fonseca R.
    Leukemia; 2008 May 22; 22(5):1044-52. PubMed ID: 18216867
    [Abstract] [Full Text] [Related]

  • 8. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature.
    Bommannan K, Sachdeva MU, Malhotra P, Kumar N, Sharma P, Naseem S, Ahluwalia J, Das R, Varma N, Prakash G, Khadwal A, Srinivasan R, Varma S.
    Blood Res; 2016 Mar 22; 51(1):23-30. PubMed ID: 27104188
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.
    Katodritou E, Terpos E, Kelaidi C, Kotsopoulou M, Delimpasi S, Kyrtsonis MC, Symeonidis A, Giannakoulas N, Stefanoudaki A, Christoulas D, Chatziaggelidou C, Gastari V, Spyridis N, Verrou E, Konstantinidou P, Zervas K, Dimopoulos MA.
    Am J Hematol; 2014 Feb 22; 89(2):145-50. PubMed ID: 24123068
    [Abstract] [Full Text] [Related]

  • 17. Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents.
    Talamo G, Dolloff NG, Sharma K, Zhu J, Malysz J.
    Rare Tumors; 2012 Jun 26; 4(3):e39. PubMed ID: 23087795
    [Abstract] [Full Text] [Related]

  • 18. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H, Qi X, Yeung J, Reece D, Xu W, Patterson B.
    Leuk Res; 2009 Feb 26; 33(2):259-62. PubMed ID: 18676019
    [Abstract] [Full Text] [Related]

  • 19. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
    Jurczyszyn A, Zawirska D, Skotnicki AB.
    Przegl Lek; 2011 Feb 26; 68(6):320-5. PubMed ID: 22039670
    [Abstract] [Full Text] [Related]

  • 20. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis.
    Jimenez-Zepeda VH, Dominguez-Martinez VJ.
    Int J Hematol; 2009 Apr 26; 89(3):259-268. PubMed ID: 19326058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.